Crowdonomics
WatchlistPortfolio
All companies
ALLEVIATE logo

ALLEVIATE

Operating

Alleviate, Inc.

Healthcare · Founded 2020

Visit website

The future of physical therapy

Post-money valuation ⓘ
$15.0M
As of Sep 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$5,967,568
Crowd $0 · Private $6.0M · 6 rounds since 2022
Latest share price
$1.33
Reg CF · Preferred Stock · Jul 2024 offering price

Financials

FY2022–FY2023 · from SEC filings · hover any figure for its source
$158K
−$1.2M
2022
$494K
−$2.1M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$158,012
$494,423
Cost of goods sold
$353,687
$399,814
Gross margin
-124%
19%
Net income
-$1,211,600
-$2,097,390
Taxes paid
$0
$0
Balance sheet
Cash
$147,030
$327,585
Accounts receivable
$26,334
$46,329
Total assets
$655,462
$585,895
Short-term debt
$2,280,000
$690,262
Long-term debt
$70,025
$222,334
Total liabilities
$2,350,025
$912,596
Other
Headcount
—
7

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$15.0M
pre-money
Reg CF · Preferred · Jul 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$1.33$0.665$1.01
May 2023Jul 2024
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Rule 506(b) · Apr 2025Closed
Raised $275KInvestors 3
Reg CF · Preferred Stock · Jul 2024Withdrawnvia StartEngine
Raised $12.8K / $1.2MInvestors 25Post-money $15M
Rule 506(b) · Debt · Jan 2024Closed
Raised $512KInvestors 22
Rule 506(c) · Preferred Stock · May 2023Closed
Raised $1.3M
Rule 506(b) · Equity · Feb 2023Closed
Raised $3.6MInvestors 66
Rule 506(b) · Convertible Note · Feb 2022Closed
Raised $305KInvestors 9

Team

3 people
Roderick Thomas McMullen
CEO, Director, Principal Accounting Officer
Luke Ferdinands
CPO, Director
Marc Joshua Tolkoff
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

66 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form DApr 21, 20250001920047-25-000002
    EDGAR
  • Form CJul 15, 20240001665160-24-001068
    EDGAR
  • Form DJan 25, 20240001920047-24-000001
    EDGAR
  • Form DFeb 15, 20230001920047-23-000001
    EDGAR
  • Form DMar 31, 20220001920047-22-000001
    EDGAR
Source: ManualCIK 0001920047Share price $1.33

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.